Drug Discovery & Development
ADVERTISEMENT
Valeant Plans $1.75B Stock Offering
June 17, 2013 4:53 pmGlobus Faces $16M Payment Over Patent Dispute
June 17, 2013 1:59 pmTeva Buying Microdose for $40M
June 17, 2013 1:25 pmPerrigo Acquires Eye-Care Portfolio
June 17, 2013 11:15 amADVERTISEMENT
Better Development of Biosimilars
June 11, 2013 12:03 pm | by Savanna Steele, PharmD, Clinical Scientist; Song Wang, PhD, Associate Statistical Science Director; Brian Healey, PharmD, Associate Director; Dirk Reitsma, MD, Vice President; PPD, Wilmington, N.C.Automating Lead Optimization
June 6, 2013 5:00 pm | by Bobby Chavli, Associate Director, Marketing, BD, and Customer Service; Hamilton Robotics, Reno, Nev.; Mary Napier, Consultant; GeneCom Group, San Francisco, Calif.Following Up on Genotoxicity
June 6, 2013 4:49 pm | by Scott Hickman, Marketing Manager, Toxicology; BioReliance Corp., Rockville, Md.Targeting Pol I to Selectively Activate p53 and Kill Cancer Cells
June 6, 2013 4:39 pm | by Sean E. O’Brien, Vice President Research; Denis Drygin, Vice President Biology; Cylene Pharmaceuticals, San Diego, Calif.
